Correlation Between Qualigen Therapeutics and Tenaris SA

Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and Tenaris SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and Tenaris SA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Qualigen Therapeutics and Tenaris SA, you can compare the effects of market volatilities on Qualigen Therapeutics and Tenaris SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of Tenaris SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and Tenaris SA.

Diversification Opportunities for Qualigen Therapeutics and Tenaris SA

-0.26

Correlation Coefficient

Qualigen Therapeutics  Tenaris SA

Very good diversification

The 3 months correlation between Qualigen and Tenaris is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and Tenaris SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tenaris SA and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with Tenaris SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tenaris SA has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and Tenaris SA go up and down completely randomly.

Pair Corralation between Qualigen Therapeutics and Tenaris SA

Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the Tenaris SA. In addition to that, Qualigen Therapeutics is 2.77 times more volatile than Tenaris SA. It trades about 0.0 of its total potential returns per unit of risk. Tenaris SA is currently generating about 0.06 per unit of volatility. If you would invest  1,881  in Tenaris SA on December 30, 2024 and sell it today you would earn a total of  108.00  from holding Tenaris SA or generate 5.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.38%
Values	Daily Returns

Qualigen Therapeutics  vs.  Tenaris SA

Qualigen Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Qualigen Therapeutics is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Tenaris SA

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Tenaris SA are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Tenaris SA is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Qualigen Therapeutics and Tenaris SA

The main advantage of trading using opposite Qualigen Therapeutics and Tenaris SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, Tenaris SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tenaris SA will offset losses from the drop in Tenaris SA's long position.

The idea behind Qualigen Therapeutics and Tenaris SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.